期刊文献+

低舒张压与心血管疾病关系的研究进展 被引量:3

Research Progress of Relationship Between Low Diastolic Blood Pressure and Cardiovascular Disease
下载PDF
导出
摘要 Stewart于1979年提出降压过度,尤其是舒张压降得过低可能增加心血管疾病并发症风险。此后大量研究逐渐证实了舒张压与心血管疾病之间存在J型曲线关系,并且这种关系同样体现在合并冠心病、糖尿病的高血压患者以及老年高血压患者中。因此,强化降压的理念受到了巨大的冲击,尤其是不同人群中究竟该如何选择降压目标值,再一次成为了临床医生们面临的难题。现在分析归纳一些大型临床试验的结果,对降压过程中低舒张压与心血管疾病的关系做一综述。 During the past 3 decades, the J-emwe relationship between diastolic blood pressure (DBP)and cardiovascular disease (CVD) has been a subject of much concern. Numerous studies have provided strong evidence for J-curve relationship between DBP and CVD in the general hypertensive patients, as well as in high-risk populations,including patients with coronary artery disease,diabetes mellitus and the elderly. As a result aggressive blood pressure-lowering has been impacted and physicians are once again stuck for what to choose as a target level. This paper analyzed the result of a few large clinical trials and reviewed the J-curve relationship between DBP and CVD to provide a basis for rational antihypertensive therapy.
出处 《心血管病学进展》 CAS 2016年第5期486-490,共5页 Advances in Cardiovascular Diseases
基金 国家自然科学基金(2016-gz19)
关键词 舒张压 心血管疾病 J型曲线 降压治疗 Diastolic blood pressure Cardiovascular disease J-curve relationship Antihypertensive therapy
  • 相关文献

参考文献30

  • 1James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults : report from the panel members ap- pointed to the Eighth Joint National Committee (JNC 8 ) [ J ]. JAMA,2014,311 (5) :507-520.
  • 2Tanna MS, Bangalore S. Antihypertensive therapy and the J-curve:fact or tic- tion? [J]. Curr Hypertens Rep,2015,17(2) :6.
  • 3The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)[ J]. Arch Intern Med, 1993,153 (2) :154-183.
  • 4Stewart IM. Relation of reduction in pressure to first myocardial infarction in pa- tients receiving treatment for severe hypertension [ J ]. Lancet, 1979,1 ( 8121 ) : 861-865.
  • 5Cmickshank JM,Thorp JM, Zacharias FJ. Benefits and potential harm of lower- ing high blood pressure [ J ]. Lancet, 1987,1 ( 8533 ) :581-584.
  • 6Boutitie F, Gueyffier F, Pocock S, et al. J-shaped relationship between blood pressure and mortality in hypertensive patients:new insights from a meta-analy- sis of individual-patient data [ J ]. Ann Intern Med, 2002,136 (6) :438 -448.
  • 7Hansson L,Zanchetti A, Carruthers SG, et al. Effects of intensive blood'pressure lowering and low-dose aspirin in patients with hypertension : principal results of the Hypertension Optimal Treatment(HOT) randomised trial. HOT Study Group [J]. Lancet,1998,351 (9118) :1755-1762.
  • 8Glynn ILl, Ltalien GJ, Sesso HD, et al. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pros- sure [ J ]. Hypertension,2002,39 ( 1 ) : 105-110.
  • 9Tringali S,Oberer CW, Huang J. Low diastolic blood pressure as a risk for all- cause mortality in VA patients[ J]. Int J Hypertens,2013 ,2013 :178780.
  • 10Shu W, Da W J, Fu LC, et al. The J-curve relationship between diastolic pressure and coronary collateral circulation in patients with single chronic total occlusion [ J]. Atherosclerosis ,2014,232( 1 ) :220-223.

二级参考文献29

  • 1刘力生.中国高血压防治指南2005年修订版[M].北京:人民卫生出版社,2006.
  • 2Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report [ J]. Hypertension, 2003, 289 (19) : 2560- 2572.
  • 3Mansia G, de Backer G, Dominiczak A, et al. 2007 ESH-ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) [ J ]. J Hypertens, 2007, 16 ( 3 ) : 135- 232.
  • 4Cooper-Dehoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease[J]. JAMA, 2010, 304( 1 ) : 61-68.
  • 5Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2.030[J].Diabetes Res Clin Pract, 2010, 87( 1 ) : 4-14.
  • 6Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12) : 1090-1101.
  • 7Hammoud T, Tanguay JF, Bourassa MG. Management of coronary artery disease: therapeutic options in patients with diabetes [ J ]. J Am Coil Cardiol, 2000,36(2) :355-365.
  • 8胡盛寿,孔灵芝.中国心血管病报告2008-2009[M].北京:中国大百科全书出版社,2009.
  • 9No authors listed. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus : results of the HOPE study and MICROHOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators [J]. Lancet, 2000,355(9200):253-259.
  • 10Morrish N J, Wang SL, Stevens LK, "et al. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes [ J ]. Diabetologia, 2001,44( suppl 2) : S14-S21.

共引文献56

同被引文献42

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部